Literature DB >> 18586903

Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis.

P A Keane1, S Liakopoulos, K T Chang, F M Heussen, S C Ongchin, A C Walsh, S R Sadda.   

Abstract

AIM: To compare the retinal morphological characteristics of eyes with choroidal neovascularisation (CNV) secondary to pathological myopia versus eyes with CNV secondary to age-related macular degeneration (AMD), using quantitative optical coherence tomography (OCT) subanalysis.
METHODS: Twenty-one eyes of 21 patients newly diagnosed as having CNV secondary to pathological myopia, and 43 consecutive cases of eyes with newly diagnosed subfoveal CNV secondary to AMD were retrospectively collected. In all patients, StratusOCT images and fluorescein angiograms (FA) were available for analysis. StratusOCT images were analysed using custom software (termed "OCTOR"), which allowed calculation of the thickness/volume of the neurosensory retina, subretinal fluid (SRF), subretinal tissue (SRT) and pigment epithelial detachments (PEDs). FA images were used to calculate CNV leakage area and CNV lesion size for each eye.
RESULTS: The total volume of neurosensory retina in the pathological myopia group was significantly less than in the AMD group (7.10 (SD 0.50) mm3 vs 7.76 (0.93) mm3, p = 0.004). The total volume of SRF in the pathological myopia group was less than in the AMD group, but the difference was not statistically significant (0.33 (1.38) mm3 vs 0.55 (0.82) mm3, p = 0.434). The total volume of SRT in the pathological myopia group was less than in the AMD group, but the difference was not statistically significant (0.16 (0.15) mm3 vs 0.36 (0.60) mm3, p = 0.144). The total volume of PED in the pathological myopia group was markedly less than in the AMD group (0.01 (0.03) mm3 vs 1.09 (1.89) mm3, p<0.001). On FA, the total leakage of CNV in the AMD group was significantly greater than in the pathological myopia group (4.17 (3.29) DAs vs 0.53 (0.58) DAs, p<0.001).
CONCLUSIONS: CNV lesions in pathological myopia were associated with considerably less retinal oedema, SRF and SRT compared with CNV associated with AMD. PEDs were almost negligible in myopic lesions compared with AMD. These findings are consistent with previous clinical and angiographic descriptions of myopic CNV as relatively small lesions with modest exudation.

Entities:  

Mesh:

Year:  2008        PMID: 18586903      PMCID: PMC2749310          DOI: 10.1136/bjo.2008.138891

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  28 in total

1.  Pathologic myopia: where are we now?.

Authors:  Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

2.  Ultrahigh resolution optical coherence tomography of the monkey fovea. Identification of retinal sublayers by correlation with semithin histology sections.

Authors:  Elisabeth M Anger; Angelika Unterhuber; Boris Hermann; Harald Sattmann; Christian Schubert; James E Morgan; Alan Cowey; Peter K Ahnelt; Wolfgang Drexler
Journal:  Exp Eye Res       Date:  2004-06       Impact factor: 3.467

3.  Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Authors: 
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

4.  Some features of ocular microcirculation in myopia.

Authors:  E S Avetisov; N F Savitskaya
Journal:  Ann Ophthalmol       Date:  1977-10

5.  Axial length measurements and fundus changes of the myopic eye.

Authors:  B J Curtin; D B Karlin
Journal:  Am J Ophthalmol       Date:  1971-01       Impact factor: 5.258

6.  Pathologic myopia.

Authors:  K G Noble; R E Carr
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

7.  Natural history of choroidal neovascularization in degenerative myopia.

Authors:  M P Avila; J J Weiter; A E Jalkh; C L Trempe; R C Pruett; C L Schepens
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

8.  Visual prognosis of disciform degeneration in myopia.

Authors:  G R Hampton; D Kohen; A C Bird
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

9.  The development of lacquer cracks in pathologic myopia.

Authors:  R M Klein; S Green
Journal:  Am J Ophthalmol       Date:  1988-09-15       Impact factor: 5.258

10.  Prevalence of myopia in the United States.

Authors:  R D Sperduto; D Seigel; J Roberts; M Rowland
Journal:  Arch Ophthalmol       Date:  1983-03
View more
  18 in total

1.  Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.

Authors:  U Introini; G Casalino; G Querques; A T Gimeno; F Scotti; F Bandello
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

2.  In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice.

Authors:  Robert Hoerster; Philipp S Muether; Sarah Vierkotten; Susanne Schröder; Bernd Kirchhof; Sascha Fauser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-16       Impact factor: 3.117

3.  Retinal pigmental epithelium elevation and external limiting membrane interruption in myopic choroidal neovascularization: correlation with activity.

Authors:  Xiaoyan Ding; Zongyi Zhan; Limei Sun; Yu Yang; Songshan Li; Aiyuan Zhang; Xiaoling Luo; Lin Lu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-07       Impact factor: 3.117

4.  [Morphological features of myopic choroidal neovascularization: differences to neovascular age-related macular degeneration].

Authors:  W Inhoffen; F Ziemssen
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

5.  [Spectral domain optical coherence tomography in the treatment of myopic choroidal neovascularization].

Authors:  M D Fischer; W Inhoffen; F Ziemssen
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

6.  Sensitivity of fluorescein angiography alone or with SD-OCT for the diagnosis of myopic choroidal neovascularization.

Authors:  Paolo Milani; Amedeo Massacesi; Marco Setaccioli; Stefania Moschini; Elena Mantovani; Stefano Ciaccia; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-26       Impact factor: 3.117

7.  Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Authors:  Paolo Milani; Marco Pellegrini; Amedeo Massacesi; Stefania Moschini; Marco Setaccioli; Davide Soranna; Antonella Zambon; Ferdinando Bottoni; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-30       Impact factor: 3.117

8.  Macular hole closure following anti-vascular endothelial growth factor injection in an eye with myopic choroidal neovascularization.

Authors:  Cheolmin Yun; Seong-Woo Kim; Kuhl Huh; Jaeryung Oh
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

9.  Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Praveen J Patel; Yanling Ouyang; Fred K Chen; Felicia Ikeji; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

10.  Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.

Authors:  Maria-Magdalena Guichard; Géraldine Peters; Cengiz Tuerksever; Christian Pruente; Katja Hatz
Journal:  Ophthalmologica       Date:  2019-08-06       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.